Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475

Richard Wayne Joseph; Jeroen Elassaiss-Schaap; Jedd D. Wolchok; Anthony M. Joshua; Antoni Ribas; F. Stephen Hodi; Mid Hamid; Caroline Robert; Adil Daud; Wan-Jon Hwu; Richard Kefford; Peter Hersey; Jeffrey S. Weber; Amita Patnaik; Dinesh Prasad De Alwis; Andrea Marie Perrone; Soonmo Peter Kang; Scot Ebbinghaus; Keaven M. Anderson; Tara C. Gangadhar

doi:10.1200/jco.2014.32.15_suppl.3015

Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475

Richard Wayne Joseph, Jeroen Elassaiss-Schaap, Jedd D. Wolchok, Anthony M. Joshua, Antoni Ribas, F. Stephen Hodi, Mid Hamid, Caroline Robert, Adil Daud, Wan-Jon Hwu, Richard Kefford, Peter Hersey, Jeffrey S. Weber, Amita Patnaik, Dinesh Prasad De Alwis, Andrea Marie Perrone, Soonmo Peter Kang, Scot Ebbinghaus, Keaven M. Anderson, Tara C. Gangadhar

Research output: Contribution to journal › Meeting abstract

Original language	English
Pages (from-to)	3015
Number of pages	1
Journal	Journal of Clinical Oncology
Volume	32
Issue number	15
DOIs	https://doi.org/10.1200/jco.2014.32.15_suppl.3015
Publication status	Published - 20 May 2014
Externally published	Yes
Event	50th Annual Meeting of the American-Society-of-Clinical-Oncology - Chicago, United States Duration: 30 May 2014 → 3 Jun 2014

Access to Document

10.1200/jco.2014.32.15_suppl.3015

Cite this

Joseph, R. W., Elassaiss-Schaap, J., Wolchok, J. D., Joshua, A. M., Ribas, A., Hodi, F. S., Hamid, M., Robert, C., Daud, A., Hwu, W-J., Kefford, R., Hersey, P., Weber, J. S., Patnaik, A., De Alwis, D. P., Perrone, A. M., Kang, S. P., Ebbinghaus, S., Anderson, K. M., & Gangadhar, T. C. (2014). Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475. Journal of Clinical Oncology, 32(15), 3015. https://doi.org/10.1200/jco.2014.32.15_suppl.3015

Joseph, Richard Wayne ; Elassaiss-Schaap, Jeroen ; Wolchok, Jedd D. ; Joshua, Anthony M. ; Ribas, Antoni ; Hodi, F. Stephen ; Hamid, Mid ; Robert, Caroline ; Daud, Adil ; Hwu, Wan-Jon ; Kefford, Richard ; Hersey, Peter ; Weber, Jeffrey S. ; Patnaik, Amita ; De Alwis, Dinesh Prasad ; Perrone, Andrea Marie ; Kang, Soonmo Peter ; Ebbinghaus, Scot ; Anderson, Keaven M. ; Gangadhar, Tara C. / Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475. In: Journal of Clinical Oncology. 2014 ; Vol. 32, No. 15. pp. 3015.

@article{efcfb5ba48ed4acfbe3225292ceef29d,

title = "Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475",

author = "Joseph, {Richard Wayne} and Jeroen Elassaiss-Schaap and Wolchok, {Jedd D.} and Joshua, {Anthony M.} and Antoni Ribas and Hodi, {F. Stephen} and Mid Hamid and Caroline Robert and Adil Daud and Wan-Jon Hwu and Richard Kefford and Peter Hersey and Weber, {Jeffrey S.} and Amita Patnaik and {De Alwis}, {Dinesh Prasad} and Perrone, {Andrea Marie} and Kang, {Soonmo Peter} and Scot Ebbinghaus and Anderson, {Keaven M.} and Gangadhar, {Tara C.}",

year = "2014",

month = may,

day = "20",

doi = "10.1200/jco.2014.32.15_suppl.3015",

language = "English",

volume = "32",

pages = "3015",

journal = "Journal of Clinical Oncology",

issn = "1527-7755",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "50th Annual Meeting of the American-Society-of-Clinical-Oncology ; Conference date: 30-05-2014 Through 03-06-2014",

}

Joseph, RW, Elassaiss-Schaap, J, Wolchok, JD, Joshua, AM, Ribas, A, Hodi, FS, Hamid, M, Robert, C, Daud, A, Hwu, W-J, Kefford, R, Hersey, P, Weber, JS, Patnaik, A, De Alwis, DP, Perrone, AM, Kang, SP, Ebbinghaus, S, Anderson, KM & Gangadhar, TC 2014, 'Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475', Journal of Clinical Oncology, vol. 32, no. 15, pp. 3015. https://doi.org/10.1200/jco.2014.32.15_suppl.3015

Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475. / Joseph, Richard Wayne; Elassaiss-Schaap, Jeroen; Wolchok, Jedd D.; Joshua, Anthony M.; Ribas, Antoni; Hodi, F. Stephen; Hamid, Mid; Robert, Caroline; Daud, Adil; Hwu, Wan-Jon; Kefford, Richard; Hersey, Peter; Weber, Jeffrey S.; Patnaik, Amita; De Alwis, Dinesh Prasad; Perrone, Andrea Marie; Kang, Soonmo Peter; Ebbinghaus, Scot; Anderson, Keaven M.; Gangadhar, Tara C.

In: Journal of Clinical Oncology, Vol. 32, No. 15, 20.05.2014, p. 3015.

Research output: Contribution to journal › Meeting abstract

TY - JOUR

T1 - Baseline tumor size as an independent prognostic factor for overall survival in patients with metastatic melanoma treated with the anti-PD-1 monoclonal antibody MK-3475

AU - Joseph, Richard Wayne

AU - Elassaiss-Schaap, Jeroen

AU - Wolchok, Jedd D.

AU - Joshua, Anthony M.

AU - Ribas, Antoni

AU - Hodi, F. Stephen

AU - Hamid, Mid

AU - Robert, Caroline

AU - Daud, Adil

AU - Hwu, Wan-Jon

AU - Kefford, Richard

AU - Hersey, Peter

AU - Weber, Jeffrey S.

AU - Patnaik, Amita

AU - De Alwis, Dinesh Prasad

AU - Perrone, Andrea Marie

AU - Kang, Soonmo Peter

AU - Ebbinghaus, Scot

AU - Anderson, Keaven M.

AU - Gangadhar, Tara C.

PY - 2014/5/20

Y1 - 2014/5/20

U2 - 10.1200/jco.2014.32.15_suppl.3015

DO - 10.1200/jco.2014.32.15_suppl.3015

M3 - Meeting abstract

VL - 32

SP - 3015

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 1527-7755

IS - 15

T2 - 50th Annual Meeting of the American-Society-of-Clinical-Oncology

Y2 - 30 May 2014 through 3 June 2014

ER -